Table III.
Results | Degree | No. (%) |
---|---|---|
DTH | >10 mm | 12 (16.5) |
5–10 mm | 12 (16.5) | |
2–5 mm | 18 (25.0) | |
<2 mm | 30 (42.0) | |
QOL | 4 | 9 (13.0) |
3 | 13 (18.0) | |
2 | 13 (18.0) | |
1 | 12 (16.0) | |
0 | 25 (35.0) | |
Fever | >39°C | 9 (13.0) |
38–39°C | 11 (15.0) | |
<38°C | 10 (14.0) | |
Cold symptoms | 5 (7.0) | |
None | 37 (51.0) | |
Skin rash | Local injection | 8 (11.0) |
Systemic | 1 (1.0) | |
None | 63 (88.0) | |
Arthralgia | – | 22 (31.0) |
Anorexia | – | 12 (17.0) |
Insomnia | – | 18 (25.0) |
DTH, delayed-type hypersensitivity; QOL, quality of life.